Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;326:1124 (24 May), doi:10.1136/bmj.326.7399.1124
F Verdon, general practitioner1, B Burnand, senior lecturer2, C-L Fallab Stubi, pharmacist3, C Bonard, general practitioner1, M Graff, general practitioner1, A Michaud, general practitioner1, T Bischoff, general practitioner1, M de Vevey, general practitioner1, J-P Studer, general practitioner1, L Herzig, general practitioner1, C Chapuis, general practitioner1, J Tissot, general practitioner1, A Pécoud, professor3, B Favrat, consultant of internal medicine3
1 General Practice Unit, University of Lausanne, rue du Bugnon 44, 1011 Lausanne, Switzerland, 2 Health Care Evaluation Unit, Institute of Social and Preventive Medicine, University of Lausanne, 3 Medical Outpatient Clinic, University of Lausanne
Correspondence to: B Favrat bernard.favrat{at}hospvd.ch
Objective To determine the subjective response to iron therapy in non-anaemic women with unexplained fatigue.
Design Double blind randomised placebo controlled trial.
Setting Academic primary care centre and eight general practices in western Switzerland.
Participants 144 women aged 18 to 55, assigned to either oral ferrous sulphate (80 mg/day of elemental iron daily; n=75) or placebo (n=69) for four weeks.
Main outcome measures Level of fatigue, measured by a 10 point visual analogue scale.
Results 136 (94%) women completed the study. Most had a low serum
ferritin concentration;
20 µg/l in 69 (51%) women. Mean age,
haemoglobin concentration, serum ferritin concentration, level of fatigue,
depression, and anxiety were similar in both groups at baseline. Both groups
were also similar for compliance and dropout rates. The level of fatigue after
one month decreased by -1.82/6.37 points (29%) in the iron group compared with
-0.85/6.46 points (13%) in the placebo group (difference 0.95 points, 95%
confidence interval 0.32 to 1.62; P=0.004). Subgroups analysis showed that
only women with ferritin concentrations
50 µg/l improved with oral
supplementation.
Conclusion Non-anaemic women with unexplained fatigue may benefit from iron supplementation. The effect may be restricted to women with low or borderline serum ferritin concentrations.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses